Rain Therapeutics Inc. (RAIN) Reports In-Line Q3 EPS

Rain Therapeutics Inc. (NASDAQ: RAIN) reported Q3 EPS of ($0.68), in-line with the analyst estimate of ($0.68).

For earnings history and earnings-related data on Rain Therapeutics Inc. (RAIN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank